Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on: January 29,2024 12

Researchers identify a potential therapeutic target against cirrhosis and liver inflammation

by University of BarcelonaA new study by a team of the University of Barcelona could promote the design of drugs to treat these pathologies. Credit: University of BarcelonaThe RNF41 protein could

Updated on:January 29,2024 12

New insights into genetic mechanisms could improve treatment of liver fibrosis

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.109301The liver is not only the larges

Updated on: March 20,2024 18

New insights into genetic mechanisms could improve treatment of liver fibrosis

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.109301The liver is not only the larges

Updated on:March 20,2024 18

Study ties diabetes and obesity to increased risk of liver cancer relapse

byOsaka Metropolitan UniversityDiabetes mellitus and obesity are risks for late postoperative recurrence of hepatocellular carcinoma. Credit: Osaka Metropolitan UniversityHepatocellular carcinom

Updated on: October 24,2024 0

Study ties diabetes and obesity to increased risk of liver cancer relapse

byOsaka Metropolitan UniversityDiabetes mellitus and obesity are risks for late postoperative recurrence of hepatocellular carcinoma. Credit: Osaka Metropolitan UniversityHepatocellular carcinom

Updated on:October 24,2024 0

New focus for chronic liver disease care

byFlinders UniversityCredit: Pixabay/CC0 Public DomainDeveloping improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology,

Updated on: April 30,2024 0

New focus for chronic liver disease care

byFlinders UniversityCredit: Pixabay/CC0 Public DomainDeveloping improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology,

Updated on:April 30,2024 0

New algorithm can predict advanced liver disease

(HealthDay)—A model that uses routine primary care data can predict the risk for advanced liver disease, according to a study published online Feb. 11 inBMJ Open.Theresa Hydes, Ph.D., from the U

Updated on: April 29,2024 19

New algorithm can predict advanced liver disease

(HealthDay)—A model that uses routine primary care data can predict the risk for advanced liver disease, according to a study published online Feb. 11 inBMJ Open.Theresa Hydes, Ph.D., from the U

Updated on:April 29,2024 19

New molecular subset of pediatric liver cancer identified

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Journal of Hepatology(2022). DOI: 10.1016/j.jhep.2022.04.035New research from Baylor College of Medicine and Texas

Updated on: May 27,2024 4

New molecular subset of pediatric liver cancer identified

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Journal of Hepatology(2022). DOI: 10.1016/j.jhep.2022.04.035New research from Baylor College of Medicine and Texas

Updated on:May 27,2024 4

Organ allocation changes lead to better survival rates for children with liver failure

byChildren's Hospital Los AngelesCredit: Pixabay/CC0 Public DomainLiver transplantation is currently the only cure for pediatric acute liver failure (PALF), a rapidly progressing and life-th

Updated on: November 11,2024 0

Organ allocation changes lead to better survival rates for children with liver failure

byChildren's Hospital Los AngelesCredit: Pixabay/CC0 Public DomainLiver transplantation is currently the only cure for pediatric acute liver failure (PALF), a rapidly progressing and life-th

Updated on:November 11,2024 0

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on: May 29,2024 0

Inosine is a promising metabolite for enhancing mitochondrial function and cellular potency

Updated on:May 29,2024 0

Broken sleep a hallmark sign of living with the most common liver disease, scientists find

byFrontiersCredit: Unsplash/CC0 Public DomainThe prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, boosted by increased ob

Updated on: December 09,2024 0

Broken sleep a hallmark sign of living with the most common liver disease, scientists find

byFrontiersCredit: Unsplash/CC0 Public DomainThe prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, boosted by increased ob

Updated on:December 09,2024 0

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on: April 03,2024 19

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on:April 03,2024 19

New immunotherapy 'highly effective' against hepatitis B

by University College LondonCredit: CC0 Public DomainScientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the worl

Updated on: May 06,2024 11

New immunotherapy 'highly effective' against hepatitis B

by University College LondonCredit: CC0 Public DomainScientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the worl

Updated on:May 06,2024 11

A novel malaria vaccine vector that targets the liver

by Kanazawa UniversityThe IVIS imaging results for the livers collected from mice on day 8 or day 224 post-administration of AAV-Luc showed that systemic administration of AAV8 induced ~24–43 tim

Updated on: March 25,2024 10

A novel malaria vaccine vector that targets the liver

by Kanazawa UniversityThe IVIS imaging results for the livers collected from mice on day 8 or day 224 post-administration of AAV-Luc showed that systemic administration of AAV8 induced ~24–43 tim

Updated on:March 25,2024 10